Project Details
Description
A Randomized Phase II Study Comparing Sequential High Dose Testosterone and Enzalutamide to Enzalutamide alone in Asymptomatic Men with Castration Resistant Metastatic Prostate Cancer: The STEP-UP Trial (Sequential Testosterone and Enzalutamide Prevents
Status | Active |
---|---|
Effective start/end date | 9/1/22 → 4/30/26 |
Funding
- JOHNS HOPKINS UNIVERSITY
- ASTELLAS PHARMA, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.